|
Variables
|
RFS
|
OS
|
|---|
|
HR
|
95%CI 1(ref)
|
P-value
|
HR
|
95%CI 1(ref)
|
P-value
|
|---|
|
Gender
|
|
Male
|
1.462
|
0.717–2.981
|
0.296
|
1.721
|
0.869–3.410
|
0.119
|
|
Female
| | | | | | |
|
Age (years)
|
0.995
|
0.974–1.016
|
0.638
|
0.997
|
0.977–1.019
|
0.813
|
|
Hormonal secretion
|
|
No
|
1.059
|
0.530–2.118
|
0.870
|
0.687
|
0.357–1.324
|
0.262
|
|
Yes
| | | | | | |
|
Comorbidities
|
|
No
|
1.082
|
0.542–2.162
|
0.823
|
0.759
|
0.394–1.461
|
0.409
|
|
Yes
| | | | | | |
|
Diameter of tumor (cm)
|
|
≤ 8.8
|
1.027
|
0.517–2.039
|
0.940
|
1.345
|
0.717–2.525
|
0.356
|
|
> 8.8
| | | | | | |
|
Tumor stage
|
|
I
|
1.257
|
0.441–3.580
|
0.669
|
2.533
|
1.107–5.793
|
0.037
|
|
II/III/IV
| | | | | | |
|
Modus operandi
|
|
Laparoscopy
|
0.925
|
0.459–1.867
|
0.829
|
1.849
|
0.899–3.803
|
0.095
|
|
Open
| | | | | | |
|
Post-recurrence adjuvant treatment
|
|
No
| | | |
1.118
|
0.572–2.185
|
0.745
|
|
Yes
| | | | | | |
|
Recurrence
|
|
No
| | | |
1.769
|
0.922–3.394
|
0.086
|
|
Yes
| | | | | | |
|
Albumin (g/L)
|
|
≤ 39
|
0.383
|
0.192–0.766
|
0.007
|
0.491
|
0.260–0.930
|
0.029
|
|
> 39
| | | | | | |
|
Ki67 index (%)
|
1.024
|
0.999–1.050
|
0.059
|
1.034
|
1.011–1.057
|
0.004
|
|
Globulin (g/L)
|
0.989
|
0.929–1.054
|
0.741
|
0.994
|
0.940–1.052
|
0.846
|
|
Hemoglobin (g/L)
|
0.974
|
0.955–0.992
|
0.006
|
0.992
|
0.978–1.006
|
0.257
|
- Bold figures indicate statistical significance at P<0.05
- Abbreviations: OS overall survival, RFS recurrence-free survival, HR hazard ratio, CI confidence interval, 1 (ref) 1 degree of freedom
